Holen Sie sich die Stockscreener-App
61.31
1.79%
-1.12
Handel nachbörslich:
63.00
1.69
+2.76%
Schlusskurs vom Vortag:
$62.43
Offen:
$62.21
24-Stunden-Volumen:
1.77M
Relative Volume:
0.79
Marktkapitalisierung:
$11.50B
Einnahmen:
$516.85M
Nettoeinkommen (Verlust:
$174.11M
KGV:
70.47
EPS:
0.87
Netto-Cashflow:
$217.38M
1W Leistung:
-0.65%
1M Leistung:
-21.33%
6M Leistung:
+53.05%
1J Leistung:
+119.91%
1-Tages-Spanne:
$60.77
$63.09
1-Wochen-Bereich:
$60.72
$65.11
52-Wochen-Spanne:
$22.96
$85.21
Doximity Inc Stock (DOCS) Company Profile
Firmenname
Doximity Inc
Sektor
Branche
Telefon
(650) 549-4330
Adresse
500 THIRD STREET, SAN FRANCISCO
Vergleichen Sie DOCS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
61.31 | 11.50B | 516.85M | 174.11M | 217.38M | 0.87 |
|
VEEV
Veeva Systems Inc
|
236.43 | 38.38B | 2.75B | 714.14M | 1.09B | 4.33 |
|
SOLV
Solventum Corp
|
75.30 | 13.03B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
HQY
Healthequity Inc
|
101.67 | 8.81B | 1.15B | 96.70M | -161.99M | 1.09 |
|
TEM
Tempus Ai Inc
|
45.74 | 7.88B | 640.44M | -743.28M | -206.93M | -11.29 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-07 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Neutral |
| 2024-11-14 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-08-09 | Hochstufung | Needham | Hold → Buy |
| 2024-07-18 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-02 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-08-09 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-08-09 | Herabstufung | Needham | Buy → Hold |
| 2023-08-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | Eingeleitet | Wells Fargo | Overweight |
| 2022-10-24 | Eingeleitet | Evercore ISI | In-line |
| 2022-10-13 | Eingeleitet | BTIG Research | Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-07-28 | Eingeleitet | Berenberg | Buy |
| 2022-05-18 | Bestätigt | BofA Securities | Neutral |
| 2022-05-18 | Bestätigt | Goldman | Buy |
| 2022-05-18 | Bestätigt | Guggenheim | Buy |
| 2022-05-18 | Bestätigt | Jefferies | Buy |
| 2022-05-18 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Bestätigt | Needham | Buy |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-04 | Eingeleitet | BofA Securities | Neutral |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-11-10 | Bestätigt | Canaccord Genuity | Buy |
| 2021-11-10 | Bestätigt | Goldman | Neutral |
| 2021-11-10 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-11-10 | Bestätigt | Needham | Buy |
| 2021-11-10 | Bestätigt | Piper Sandler | Overweight |
| 2021-08-26 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-07-19 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-19 | Eingeleitet | Goldman | Neutral |
| 2021-07-19 | Eingeleitet | JP Morgan | Overweight |
| 2021-07-19 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-19 | Eingeleitet | Raymond James | Outperform |
| 2021-07-19 | Eingeleitet | SVB Leerink | Outperform |
| 2021-07-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Doximity Inc Aktie (DOCS) Neueste Nachrichten
Counterpoint Mutual Funds LLC Invests $1.82 Million in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Zurcher Kantonalbank Zurich Cantonalbank Purchases 7,351 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Skandinaviska Enskilda Banken AB publ Decreases Stake in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
William Blair Investment Management LLC Sells 244,283 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity put volume heavy and directionally bearish - TipRanks
5,000 Shares in Doximity, Inc. (NASDAQ:DOCS) Acquired by one8zero8 LLC - MarketBeat
Rakuten Securities Inc. Boosts Stock Holdings in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Quantbot Technologies LP Acquires New Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Charles Schwab Investment Management Inc. Increases Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Assetmark Inc. Buys 10,529 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Prosperity Wealth Management Inc. Sells 3,935 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Analysts Set Doximity, Inc. (NASDAQ:DOCS) PT at $64.22 - MarketBeat
Moran Wealth Management LLC Acquires New Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Here's What Doximity's (NYSE:DOCS) Strong Returns On Capital Mean - Yahoo Canada Finance
US Bancorp DE Increases Position in Doximity, Inc. (NASDAQ:DOCS) - Defense World
Doximity, Inc. (NASDAQ:DOCS) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Mizuho raises Doximity stock price target to $65 from $55 - MSN
Doximity Insiders Sell US$62m Of Stock, Possibly Signalling Caution - Simply Wall St
CEOs At 197 Companies Made Big Stock Sales Lately - Forbes
Truist Financial Corp Takes $307,000 Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Aigen Investment Management LP Reduces Stock Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Where are the Opportunities in (DOCS) - news.stocktradersdaily.com
Bank of New York Mellon Corp Sells 42,208 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Plato Investment Management Ltd Purchases New Shares in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Oppenheimer & Co. Inc. Has $1.61 Million Stake in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
FY2027 EPS Estimates for Doximity Boosted by Leerink Partnrs - MarketBeat
Doximity, Inc. (DOCS): Among The Stocks With At Least $10 Million In Insider Sales Recently - Yahoo Finance
Behind the Scenes of Doximity's Latest Options Trends - Benzinga
10 Stocks With At Least $10 Million In Insider Sales Recently - Insider Monkey
Commit To Buy Doximity At $47.50, Earn 15.8% Using Options - Nasdaq
IFP Advisors Inc Increases Stock Position in Doximity, Inc. (NASDAQ:DOCS) - Defense World
FY2027 EPS Estimates for Doximity Lifted by Leerink Partnrs - Defense World
Doximity director Kira Wampler sells $141,780 in stock By Investing.com - Investing.com South Africa
Doximity director Kira Wampler sells $141,780 in stock - Investing.com India
DBS Group Digital Transformation Strategy Analysis Report 2025: Technology Initiatives, Accelerators, Incubators, and Programs - GlobeNewswire Inc.
IMMINENT DOCS DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Doximity, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
CIBC Asset Management Inc Makes New Investment in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity, Inc. (NASDAQ:DOCS) Shares Purchased by Sanctuary Advisors LLC - Defense World
SBI Securities Co. Ltd. Acquires New Shares in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
5,740 Shares in Doximity, Inc. (NASDAQ:DOCS) Bought by West Michigan Advisors LLC - MarketBeat
New York State Common Retirement Fund Acquires 75,119 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Finanzdaten der Doximity Inc-Aktie (DOCS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.20%
8.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):